Evidence map›Paper›PMID 39921807›Full record

ArticleMolecular biology reports2025

Inhibiting HSP90 changes the expression pattern of PINK1 and BNIP3 and induces oxidative stress in colon cancer cells.

Ejlal Abu-El-Rub, Ayman Alzu'bi, Fatimah A Almahasneh, Ramada R Khaswaneh, Rawan Almazari, Amani Kasasbeh, Ala A Aldamen, Heba F Ai-Jariri, Amal Alomari, Tuqa Yousef and 1 more

Abstract read
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ejlal Abu-El-RubDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan. ejlal.abuelrub@yu.edu.jo.
Ayman Alzu'biDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Fatimah A AlmahasnehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Ramada R KhaswanehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Rawan AlmazariDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Amani KasasbehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Ala A AldamenDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Heba F Ai-JaririDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Amal AlomariDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Tuqa YousefDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Raed M Al-ZoubiSurgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar. ralzoubi@hamad.qa.

Funding

Yarmouk University 29/2021 and 13/2022
6 · The paper itself

Abstract

backgroundCancer cells can modulate the expression of many proteins that are essential for supporting their uncontrolled proliferation. Heat shock protein 90 (HSP90) is ubiquitously expressed in most cell types and participates in controlling many survival pathways. Cancer cells utilize HSP90 in order to prolong their survival, thus they tend to overexpress it. Based on its importance for cancer cells, we aim to investigate the molecular mechanisms that link HSP90 inhibition in colon cancer cells with oxidative stress and mitochondrial stress-related regulators. MATERIALS AND

methodsWe used RKO colon cancer cells, blocking HSP90 with the inhibitor AT13387 and HSP90 siRNA. Cell proliferation and apoptosis were measured via CCK8 ELISA and Fluorescent Apoptosis Assays. Western blotting and immunocytochemistry assessed oxidative and mitochondrial stress markers BNIP3, PINK1, GP91/NOX2, and IRE1α in treated cells.

resultsOur findings reveal that inhibiting HSP90 with AT13387 reduces RKO cell viability by suppressing proliferation and enhancing Annexin-V expression, indicative of increased apoptosis. This rise in apoptosis is associated with PINK1 downregulation and BNIP3 upregulation, markers of mitochondrial dysfunction and oxidative stress, respectively. Additionally, AT13387 treatment elevated the protein level of GP91, a marker of oxidative stress, and IRE1α, a marker of ER stress. Similarly, genetic knockdown of HSP90 in RKO cells produced comparable effects, including reduced cell survival and a decreased PINK1/BNIP3 ratio.

conclusionTargeting HSP90 in colon cancer cells disrupts their survival by decreasing PINK1 and increasing BNIP3, which activates oxidative and endoplasmic reticulum stress, ultimately triggering apoptosis.

Indexed as

Colonic NeoplasmsHSP90 Heat-Shock ProteinsMembrane ProteinsOxidative StressProtein KinasesProto-Oncogene ProteinsApoptosisCell Line, TumorCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticHumansMitochondriaMitochondrial ProteinsPTEN-Induced Putative KinaseRNA, Small InterferingBNIP3 protein, humanHSP90 Heat-Shock ProteinsMembrane ProteinsMitochondrial ProteinsProtein KinasesProto-Oncogene ProteinsPTEN-Induced Putative KinaseRNA, Small InterferingApoptosisBNIP3HSP90Oxidative stressPINK1RKO cells

Identifiers

PMID39921807
PMCPMC11807072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.